logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Asia Allied Inf (00711) spent 110.3 thousand Hong Kong dollars to repurchase 252 thousand shares on January 22nd.

date
19:25 22/01/2025
avatar
GMT Eight
Asia United Infrastructure Holdings (00711) announced that it will invest 110,300 Hong Kong dollars on January 22, 2025...
ASIA ALLIED INF (00711) announced on January 22, 2025 that they will buy back 252,000 shares at a price of 0.435-0.44 Hong Kong dollars per share, with a total expenditure of 110,300 Hong Kong dollars.
Related Articles
HK Stock
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.
HK Stock
MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.
China Stock
Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.
HK Stock
MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.
HK Stock
Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
China Stock
RECOMMEND
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
icon
02/03/2026
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
icon
02/03/2026
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
icon
02/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.